Display Settings:

Format

Send to:

Choose Destination
    Curr Opin Infect Dis. 2001 Dec;14(6):693-6.

    Coccidioidomycosis: efficacy of new agents and future prospects.

    Source

    Department of Medicine, Stanford University, Stanford, California, USA. polishmd@earthlink.net

    Abstract

    Recent studies have contributed to our understanding of risk factors for severe and potentially life-threatening infections with Coccidioides immitis, allowing a more rational approach to initiation of antifungal therapy for this infection, as well as determining its intensity and duration. A large randomized trial found that itraconazole and fluconazole had similar efficacies in the treatment of progressive nonmeningeal coccidioidomycosis. An animal model of coccidioidal meningitis suggested potential efficacy of systemically administered liposomal amphotericin B. Investigational agents that have activity against C. immitis include posaconazole, voriconazole, caspofungin, and sordarin derivatives.

    PMID:
    11964886
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk